ASCO 2024

With 2 planned launches, Boehringer Ingelheim looks to make a name for itself in oncology
Fierce Pharma
Mon, 06/10/24 - 06:07 pm
Boehringer Ingelheim
oncology
ASCO 2024
DDLPS
glioblastoma
ASCO24: BillionToOne unveils results from tumour profiling test comparison
Clinical Trials Arena
Wed, 06/5/24 - 11:09 am
ASCO 2024
Billiontoone
tumor profiling
ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation
Fierce Pharma
Mon, 06/3/24 - 12:10 pm
ASCO 2024
AstraZeneca
Tagrisso
Imfinzi
lung cancer
non-small cell lung cancer
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena
Mon, 06/3/24 - 12:06 pm
ASCO 2024
AbbVie
antibody-drug conjugates
Teliso-V
ABBV-400
ABBV-706
solid tumors
ASCO 24: Data shows survival benefit with J&J’s subcutaneous Rybrevant
Clinical Trials Arena
Mon, 06/3/24 - 12:03 pm
ASCO 2024
JNJ
Rybrevant
non-small cell lung cancer
ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
ASCO 2024
Bristol Myers Squibb
Amgen
KRAS inhibitors
Krazati
non-small cell lung cancer
ASCO: Jazz shares 'unprecedented' HER2 biliary tract cancer data ahead of FDA decision
Fierce Biotech
Sun, 06/2/24 - 02:48 pm
ASCO 2024
Jazz Pharmaceuticals
advanced biliary tract cancer
zanidatamab
ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer
Fierce Pharma
Sun, 06/2/24 - 02:46 pm
ASCO 2024
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
ASCO: GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive
Sun, 06/2/24 - 02:45 pm
ASCO 2024
GSK
Blenrep
mutliple myeloma
Takeda
Velcade
ASCO: Early Purple data gain ground in metastatic pancreatic cancer
Fierce Biotech
Sun, 06/2/24 - 02:42 pm
ASCO 2024
Purple Biotech
pancreatic cancer
CM24
ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
ASCO 2024
Merus
JNJ
CAR-T
Legend Biotech
Pfizer
Genmab
Nanobiotix
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive
Fri, 05/31/24 - 10:50 am
Novartis
Scemblix
ASCO 2024
clinical trials
CML
Novartis brings augmented reality tech to ASCO to simulate leukemia patient experience
Fierce Pharma
Thu, 05/30/24 - 11:32 am
Novartis
ASCO 2024
augmented reality
patients
CML
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena
Tue, 05/28/24 - 10:36 pm
ASCO 2024
Rakuten Medical
photoimmunotherapy
ASP-1929
Keytruda
HNSCC
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors
ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data
BioSpace
Fri, 05/24/24 - 11:31 am
ASCO 2024
Nimbus Therapeutics
NDI-101150
solid tumors
clinical trials
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena
Fri, 05/24/24 - 11:25 am
ASCO 2024
Verastem
avutometinib
pancreatic cancer
clinical trials
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
BioSpace
Fri, 05/24/24 - 11:20 am
ASCO 2024
JNJ
JNJ-6420
prostate cancer
clinical trials
patient deaths
radiopharmaceuticals
ASCO: AffyImmune claims a first with CAR-T for solid tumours
Pharmaphorum
Fri, 05/24/24 - 11:02 am
ASCO 2024
AffyImmune Therapeutics
solid tumors
CAR-T

Pages